Literature DB >> 23718168

Duodenal infusion of feces for recurrent Clostridium difficile.

Els van Nood, Marcel G W Dijkgraaf, Josbert J Keller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23718168     DOI： 10.1056/NEJMc1303919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Microbiome as mediator: Do systemic infections start in the gut?

Authors:  Melissa Latorre; Suneeta Krishnareddy; Daniel E Freedberg
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 2.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 3.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 4.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

Review 5.  Microbiota-mediated inflammation and antimicrobial defense in the intestine.

Authors:  Silvia Caballero; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

Review 6.  SSAT State-of-the-Art Conference: Advancements in the Microbiome.

Authors:  Miquell O Miller; Purna C Kashyap; Sarah L Becker; Ryan M Thomas; Richard A Hodin; George Miller; Mautin Hundeyin; Smruti Pushalkar; Deirdre Cohen; Deepak Saxena; Benjamin D Shogan; Gareth J Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2021-07       Impact factor: 3.452

Review 7.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

Review 8.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

9.  Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.

Authors:  Monika Fischer; Dina Kao; Shama R Mehta; Tracey Martin; Joseph Dimitry; Ammar H Keshteli; Gwendolyn K Cook; Emmalee Phelps; Brian W Sipe; Huiping Xu; Colleen R Kelly
Journal:  Am J Gastroenterol       Date:  2016-05-17       Impact factor: 10.864

10.  Kibdelomycin is a potent and selective agent against toxigenic Clostridium difficile.

Authors:  Lynn Miesel; David W Hecht; James R Osmolski; Dale Gerding; Amy Flattery; Fangbiao Li; Jing Lan; Philip Lipari; Jon D Polishook; Lianzhu Liang; Jenny Liu; David B Olsen; Sheo B Singh
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.